<DOC>
	<DOCNO>NCT00692094</DOCNO>
	<brief_summary>The primary focus five-year study optimize melatonin dose regimen synchronize body clock elderly blind individual 24-hour day .</brief_summary>
	<brief_title>Blind Elderly Melatonin Treatment Study</brief_title>
	<detailed_description>The investigator intend study many 26 subject four melatonin treatment regimen , involve dose step-down melatonin dose reduce gradually find low effective dose . The 4 treatment plan differ start dose time administration . Successfully treated subject enter one-year intensive assessment safety efficacy melatonin treatment subject take dose one year complete biweekly assessment efficacy side-effects . The final phase study involve placebo discontinuation , subject 's circadian rhythm return baseline rhythm ( may take 6 month subject ) .</detailed_description>
	<mesh_term>Blindness</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Adults 55100 year old Blindness least one year , verify ophthalmologic exam Ability comply requirement experimental protocol No clinically significant abnormality ( blindness ) general physical examination Subjects must competent sign inform consent Abnormal heart , liver kidney function ; current Axis I psychiatric substance abuse disorder accord DSMIV Manual A diagnosis obstructive sleep apnea ( apnea index &gt; 10 ) nocturnal myoclonus ( &gt; 10 associate arousals/hour ) External demand limit ability maintain regular schedule , e.g. , night shift work</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>melatonin</keyword>
	<keyword>circadian rhythm</keyword>
	<keyword>sleep</keyword>
</DOC>